Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
93.614,34
0,10%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE AptarGroup Inc (ATR) AptarGroup Inc (ATR) Notizie

ATR

AptarGroup (ATR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ATR
DataOraFonteTitoloSimboloCompagnia
03/12/202418:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ATRAptarGroup Inc
22/11/202422:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ATRAptarGroup Inc
13/11/202423:00Business WireAptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by ForbesNYSE:ATRAptarGroup Inc
28/10/202419:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ATRAptarGroup Inc
25/10/202416:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ATRAptarGroup Inc
24/10/202423:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:ATRAptarGroup Inc
24/10/202423:00Business WireAptar Reports Third Quarter 2024 ResultsNYSE:ATRAptarGroup Inc
22/10/202423:00Business WireAptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical DevicesNYSE:ATRAptarGroup Inc
10/10/202423:00Business WireAptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly DividendNYSE:ATRAptarGroup Inc
23/09/202423:00Business WireAptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology ProgramNYSE:ATRAptarGroup Inc
15/08/202423:00Business WireAptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including AnaphylaxisNYSE:ATRAptarGroup Inc
25/07/202423:21Business WireDaniel Ackerman Named Aptar’s Chief Accounting OfficerNYSE:ATRAptarGroup Inc
25/07/202423:20Business WireAptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the CompanyNYSE:ATRAptarGroup Inc
25/07/202423:00Business WireAptar Reports Second Quarter 2024 ResultsNYSE:ATRAptarGroup Inc
11/07/202423:00Business WireAptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong PerformanceNYSE:ATRAptarGroup Inc
25/06/202423:00Business WireAptar Named One of the World’s Most Sustainable Companies 2024 by TIMENYSE:ATRAptarGroup Inc
12/06/202418:15Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:ATRAptarGroup Inc
06/06/202423:00Business WireAptar Named One of America’s Climate Leaders by USA TodayNYSE:ATRAptarGroup Inc
30/05/202423:00Business WireAptar Releases 2023 Corporate Sustainability / ESG ReportNYSE:ATRAptarGroup Inc
21/05/202423:12Business WireAptar Receives Platinum Rating from EcoVadis for the Fourth Consecutive YearNYSE:ATRAptarGroup Inc
25/04/202423:00Business WireAptar Reports First Quarter 2024 ResultsNYSE:ATRAptarGroup Inc
11/04/202423:00Business WireAptar Declares Quarterly DividendNYSE:ATRAptarGroup Inc
20/03/202422:00Business WireAptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive YearNYSE:ATRAptarGroup Inc
08/03/202414:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:ATRAptarGroup Inc
29/02/202423:00Business WireAptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive YearNYSE:ATRAptarGroup Inc
09/02/202422:14Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:ATRAptarGroup Inc
09/02/202416:00Business WireAptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health SolutionsNYSE:ATRAptarGroup Inc
08/02/202423:00Business WireAptar Reports Fourth Quarter and Annual 2023 ResultsNYSE:ATRAptarGroup Inc
29/01/202413:36Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:ATRAptarGroup Inc
23/01/202423:00Business WireAptar Named One of America’s Most Responsible Companies by Newsweek for the Fifth Consecutive YearNYSE:ATRAptarGroup Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ATR

La tua Cronologia

AQSE
LCOP.GB
WisdomTree Commodity Sec...
AQSE
USDV.GB
SPDR S&P US Dividend Ari...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network